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The basic mechanism of coagulation is an enzJnne cascade as rccognised by
Macrenrexs and DAvrEs and RerNorF about l0 years ago (1, 15).
A model of a cascade can easily be constructed. \il?hen a small amount of entero-
kinase is added to a mixftre of trypsinogen and chymotrypsinoged' the entero-
kinase will convert the trypsinogen into trypsin and the trypsin will convert the
chynotrypsinog€n into chymotrypsin:
enterokinase
trypsinogen 
' 
-' trYpsin
chymotryrpsinogen -l-* chymotrypsin
There are few reasols why this example would not actually work in practice'
but we will come to this later.
Originatty it was thought that all coagUlation factors were proenzymes, which
mun bi converted into enzvmes. This resulted in the well knowu classical
6crdescheme:
. sfte
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XII --* XIL
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xI __+ xL
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I _-+ fibrin
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Tealr I
!
Inhibition of coagulation factors IIaiJJfrT:r5i by various serine esterase inhibitors
Structure . Molai
concentration
Inhibition (o/o) of factor
II" VII. X"
I pCl-Ph-o-C(:O)-NH-Me
2 Ph-O-C(:O)-NH-Me
3 .Ph-O-C(-O)-NH-EI
Ph-O-C(-O)-NH-Pr
5 pCt-Ph-O-C(-O)-NH-Ph
6 pMe-Ph-O-C(:O)-NH-Me
7 oNOz-Ph-O-C(:O)-N-Me,
8 oMeg-N-Ph-O-C(:O)-NH-Me ,
9 rzNHu-Ph-O-C(:O);\(Q11.;,
10 zzNOz-Ph-O-C(:O)=N(CH3),
11 rz(Mti:-CH(CH3))Ph-O-C(:O)NHCHs'
12 Ph,-N-C(:O)-O-Ph-oNO2pCOOH
13 (pNOz-Ph-O),-P(:O)-Ph
14 (pNOz-Ph-O)z-P(:O)-Cyc. hgx.
15 (pNOu*Ph-O)r-P( = O)-Isoprop.
16 @NOr-Ph-O)z-P(:O)-eth.
1?, (pNOz+h-O)r:P( : O)-CH2-Phe
18 (pNOr,Ph-O)z-P(:O)-O-Ph
19 @NOz-Ph-O)z-P(:O)-NH-Me
20 (cl-Ph-o)z-P(:o)-NHz
2L (CI-Pi-O),-P(:O)-NH-Me
22 (CI-Ph-O),-P(:O)-NMe:
23 (2NOz-Ph-O)z-P(:O)-NH-Phe
2a 6NOz-Ph-O)u-P(:OFNMez
25 (Ph-O),-P(:O)-NH-Me
2xL0-4
2x lO c
5 x 1O-+
5 x 10-4
l0-3
5 x 10=a
10-3
10-4
2 x 10-a
l0-1
2xL0-4
4 x 10-4
2xlA-4
.2  x  10- r
4 x L0-a,
2x l0-s
2Y: !A-4
4x I,0-4
10-3
. l0-s
2x  10-s
5 x lO-s
l0-4
1.5 x 10-4
10-5
2 x 10*5
4 x 10-5
10=r
2xl0-s
2 x 10-5
5 x 10-5
4x  10- r
10-4
L0-5
2 x 10-s
2xlO-1
4 x 10-1
10-3
2xlO-1
5 x 10-r
5 x 10-{
10-3
2 x 10-4
5 x 1.0-1
10-4
2xLA-4
2 x 10-1
5 x 10-4
10
0
0
t 7 0
0 0
0 0
. 5 0
30 20
1 0 0
20 10
2A t0
30 15
2 4 5
30.  5
' 0 0
. 0 0
. 3 5 0
2 5 0
5 0
45 30
70 ??
80 35
>95 3A
>95 55
6 5 0
6 5 0
9 0 0
80 <5
>95 10
>95 2n
>95 25
>95 30
>95 >65
>95 >65
>95'  30
>95 : 40
5 0 0
6 0 0
>95 0
>95 0
>95 &
1 5 0
2 0 0
70 20
85 40
3 5 0
4 0 0
t5  <5
10  <5
0 0
1 0 0
< l
< l
25
0
0
< 5
< 5
i.
F[]
[,
F .E:-ls
{\'lh
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NON-LINEAR REACTION SCHEME
I-ater it was recognised that the factors V and VIII probably are not proenzym€s.
These two factors 
-have 
some properties in common, among them the fact that
it was impossible to find any enzymatic action in them.
On ttre^otn.r hand the faltors iI, VII, IX and X also have many propefiies
il common:
I. The physicai ploperties are Yery much alike. This makes them difficult to- 
.rpar'it.. I-IntiLquite recently, it il,epended-upo4.$e geografic location whether
oni considered {hem as one protein or as four different ones.
2. A-ll four are dependent upon vitaminl(.
3. -{ll lour appeai to be pfoenzymes_ of_serine_prote:tses. For.factor II this has
bem proviei beyond reasonable doubt by M_ggNyssoN (2) who determined
the primary structure of thrombin. For factor X it^has beenproven by EsNour
andisvEs6N (14) and TrreNr et al. (21). For the factors VII and IX however,
this is less certain, as no data on the piimary strucnre of these factors exist'
In order to determine the (pro)serine-esterase character of these factors we
took a large series (78) of serinL-esterase ryhibitgr,q of different types,.phosphate,
carbamate"s etc. anddetermined what was their inhibiting action upon the different
coaeulation factors (13). The pr:rified activated factors were incubated with the
i"liUitlo" und.er standardised cionditions, and the residualactivity was determined
after a certain time. Sorne results are shown in Table 1.
From these and similar experiments we drew the conclusions that:
- The four facrors II, VII, IX and X are indeed serine esterases in their activated
form. This is the more obvious as the nor-activated forms axe not inhibited.
- The for:r factors must have different active sites, as there are inhibitors that
specifically inhibit one or two or three factors (Table 2).
Tnrr-s 2
specific inhili1iqn of various 
""ur"l?:io; *ll1llr 
selected serine sterase inhibitors
Structure Molar conc. II' V VII' VIII IXa X'
2r (cl-Ph-o):-P(:o)-NHCH3
19 (pNO,-Ph-o->-P(:O)-NH-CH3
1l zdMez-CH(CH3).Ph-O-C(:O)NHCH3
26 cH3-Ph-O-q:o)-NHCH3
l6 !:NOz-Ph-O):-P(:O)-eth
r p-cl-Ph-o-c:(:o)-NH-Me
2 Ph-o-c(:o)-NH-Me
l? CINO,-Ph-O),-P(:O)-CH,-Ph
27 cH3-Ph-o-c(:o)-NH-Ph
10-4
2 x 10-s
2xLO"t
2 x 10-4
2 x 10-5
2 x 10-1
10-3
4 x 10-s
4x  10-1
0 3 0
0 r 0  0
0 0 0
o 2 0 2 0
0 0 5
0  0 2 0
0  0 2 5
0 < 5  5 0
0 < 5  0
0 0 0
6 0 0 0
5  0 2 0
0 0 0
9 5  0 4 0
2 0 0 0
0  0 3 0
9 5  0 6 5
3 A  A 4 5
Further the factors V and VIII are not inhibited, neither in their plasmatic nor
in their so-called activated form (see below).
If we are to have an enzyme casiade as the backbone of coagulation it will have
to look like this:
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l[ ---+ IXa
J
VII. *--VII
.1.
x _ _-___._+
II -+ Itra
The first reactions axe triggered by activated contact product for the intrinsic
and by tissue thromboplastin for the extrinsic pathway. Activated contact product
and tissue thromboplastin will not be discussed further here, as this would lead
us offthe mainline of reasoniug in this discussion. Essentially, the idea of a cascade
is maintained but the number of steps is reduced.
Fig, 1. Product fbrmation in an enzyme cascade.
0 * concentration of triggering enzyme,
I - concentration of the first product,
2 - concentration of the product of a two-step ca-
scade,
4 -- concentration of the product of a four-step
cascade
(it is assumed that simpie first order kinetics apply).
xa
J
rU
,
o
The kinetic behaviour can be accurately calculated (6). It can also be seen
intuitively. When we return to our first example concerning enterokinase, trypsin
and chyrnotrypsin, and we assume zero order kinetics, then the constant amoult
of enterokinase will cause a constant conversion rate of trypsinogen. This will
cause an increase in the trypsin concentration that is linear in time. Hence the
velocity of chSrmotrypsin conversion will increase linearly in time and the amount
of chymotrypsin will increase as a second order funmion. fn a n-step cascade the
last product will arise as a n-power function (Fig. 1).
Such kinetic behaviour can account for two characteristic features of the
coagulation process viz. a) the "magnifying" effect that cau-ses that a few molecules
of activated contact product can bring about a massive formation of fibrin and
b) the "avalanche" effect. This indicates that the small triggering which stimulates
the formation of activated contact product, eventually has large results, but that
it requires time to achieve them, because the development of the reactions goe$
through a latent phase ofbarely visible production ofthe end product.
Such a cascade does not, however, account for two equally specific features
of coagulation, namely:
a) The extraordinary specificity, that results in a fact that four factors that are
so riruch alike still act in an ordered sequence without a lot of side reactions going
on (it is in this respect for instance that our first example of a simple cascade
would go wrong).
b) The self-li-nriring character, which makes that coagulation in aiao does qot
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end in a complete thrombosis. It is here that the factors V and VIII enter into
the scene.
It has been found that for factor Vo to be able to convert factor II it has to be
adsorbed together with factor V at a phospholipid-water interphase. The evidence
tbr this is of three kinds:
a) It has been proven impossible to find prothrombinase activity in preparations
that did not contain factor X", Caz+-ions and phospholipids togefher. The same
holds for Xase and factor IX, and VIIL
b) It has been proven thar both factor Xu and factor V adsorb onto phospho-
lipid. The binding of Xu is enhanced by Caz+-ions. The binding of V is inhibited
by C,a2--ions. The optirnal Ca is where about equimolar quantities of )G and V
are bound. Again the same holds for factors IXu and VIII (2).
c) The kinetics of prothrombinase formation are not in accordance with the
enzymatic action of one of the factors upon the other, but lend support to the
scheme: 
kr
phospholipid + V +phospholipid - V
l(z
phospholipid * X, + phospholipid - Xn
ki
V - phospholipid * Xu + Il-ase
k i
X" - phospholipid -; V + Il-ase
It is interesting to note that we found no evidence of kr and kt' to be very dif-
ferent. This suggests that the primary action in the formation of these complexes
is between the phospholipid and the protein rather than between one protein and
another factor adsorbed at the phospholipid (5).
The fact that factor X, binds via Ca2+-ions suggests that an ionic site of the
protein interacts with an ionic site at the phospholipid surface.
We did a set of experiments where we substituted Ba-stearate for phospholipid.
It turned out that factor V binds irreversibly to such a hydrophobic powder,
but that it keeps at least part of its activity when adsorbed. This makes us think
that hydrophobic interactions are involved in the binding of factor V (11).
For a phospholipid to have thromboplastic properties, it must present a mosaic
or hydrophilic and hydrophobic attachment site. Whether the attachment sites
are preexistant or induced remains open (Fig. 2).
As no enzlmatic activify of factor V alone is known, what then can be the
function of factor V?
There are two possibilities:
a) Factor V could change the conformation of factor Xa so that its acive site is
able to work on prothrombin, or
b) Factor V could provide accessory binding sites necessary to hold factor
II in a position appropriate for attack by factor Xu.
In order to investigate this we did experiments with synthetic substrates.
We took tosylarginine methylester (TAMe) which is a poor subsrrare for Xujust as prothxombin. It showed that it was impossible to improve the TAMe
splitting by adding factor V or phospholipid (Table 3).
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The splitting could be inhibited by anti-factor-X-antibody_ whic,h makes the
possibiliry of a-non-specific esterase frLing these results rather less likely'^ 
We think it more-likely than not thai factor V acts by ployiding accessory
bindine sites for the protfirombin. It also seems that part of the prothrombin
molecile has a specifi? affinity for factor V (8). To illustrate.this I will briefly
review the work o?Marn, HerieHlN, JecrsoN aid othefs (a. o. 4) on the activation
of prothrombin.
Fie. 2. Schematic view of prothrombinase. The hydrophobic binding sites are given as- --- --sqd*., 
the hydrophjhc ones as circles. The-black circles represent Ca-ions.
Tagr,s 3
The influence of factor V, Ca2+ and phospholipid in the TAMe esterase activity of factor X
250
250
250
254
250
250
375
375
500
500
625
0.0
0.17
0.1?
0.17
o.r7
0.17
0.17
1.0
1.0
1.0
1.0
0.o 0.0 r.00
0.0 0.0 0.85
4.O 0.0 0.75
4.0 7.5 0.70
24.O 7.5 0.50
24.0 15.0 0.30
24.0 22.5 0.50
24.0 22.5 0.45
24.0 22.5 0.85
24.0 30.0 0.80
24.0 37.5 1.00
The experiments were carried out at pH 8.0 in l0mu TAMe at pH 8.0
Prothrombin is a siqgle polypeptide chain-protein which in the course of its
activation undergoes tfi'ree cl6iviges. The fiist- step renders. fragment I (FI)
anA intetmeAi"te-I (I1). This step can be brought about by either thrombin or
""ti*tia 
Actor X.'T[e second step splits of fragment 2 and leaves behind
i"iirr"Ai"t" 2.ln a third step inter-me&ate 2 is spfit in the a- and B-chains of
246
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thrombin. These remain attached by a disulfide bond. The last rwo sreps can be
brought about by factor Xo only.
_ . 
F] qmtains !0 o1o 9f the carbohydrates, and is the part of the molecule thatbinds ca, and via ca binds to phospholipid. The ca-binding propeffy is endowed
in the vitamin K-depeldent step of thd prothrombin syntfieisis (A, iO, tZ;.
Intermediate I can be converted into-the normal tlirombin, but much more
slowly than factor^II, jrist a9 $e abnormal prorhrombin (PIVKA-II) synthecizedin the absence of functional factor rr. F2 seems to be bound to facioi v.
If yo." asked m-e to speculate on the most likely course of events in prothrombin
activation, I think that all three factors Xs,, V, and II bind to phospirolipid, that
Xu first splits off_Fl, so^rhar prothrombin would no Ionger atta6h to'the domplex,
if factor V would not fix it via fragment 2. Then factoi X, splits intermediite f
at other sites. Much less is known on the factors IXu and vIII, but what we know
argues in favour of a complete parallelism with Xu and V. Factors V and VIII
thus belong-to a cl?ss o{proteins that have to sit besides active enzymes in order
to.specifically modify their z.ctivity. We have therefore called them para-enzJ)mes(7).
It may be that para-enzymes occur much more often than we now think.
Enzyme-paraenzyme complexes at an interphase occur in coagulation and also
in the action of the complement system. The situation in thes-e complexes may
be thouglt of as half-membranes. It may well be that at membrane-*ater inter-
phases the close cooperation between an enzyme and a non-enzJrynatic protein
occlus fairly often. This might in part-account for the well known diffiiulty of
separatiag and reconstituting funaional units in membranes.
I think there is at bast oqe specific example of this. In trying ro separate the
enzymes responsible for oxidative phosphorylation in mitochondria Ricrnn and
coworkers could isolate a particle that had oligrmycin-sensitive ATPase activity.
This particle coyl^d be furrher_sgparatgq in plospholipid, ATpase (oligomycii-
-insensitive) and factor 0 which in itself was inaclive.-These three iould bL re-
con_.sJituted to
-give oligomycin-sensitive ATP-ase (18).We see that factors V and_VII may_well account fdr ihe extraordinary specificity
in the. coagulation sysrem by.providi"g accessory binding sites. we-think they
alsg-PlaV a role in_the determination of the self-limiting character of coagulation.
we know that factor V and factor vIII must be "adtivated" before t-hev can
take part in the coagulation process. This "activation" is not a proenzyme-"nrym.
conversionl it.probably is a polyme-r-monomer transition. This prociss is partly
spontaneous,_but can be-greatly_enhanced by rhrombin (or RW-v for v) (tz).
The tfuombin activated factor V is much more labile than the original prbciucl.
This causes a rransient burst of activity of factor v in the presencJof th?ombin,
9ol_npared to a steady low activiry in its absence. At the nroment, we favour thefollowing type of reaction r";i3*ffi",his phenomenon:
V (tetramer) =-:.4 . v (monomet 
= 
4 . v (monomer) =: 2 . V (dimer, inactive)
The inactivation of factor V follows second orderkinetics. This nbt only holds
f^nr vu_in_solution, but also for va when it forms part of prothrombinase.'Active
firctor V therefore inactivates prothrombinase. It thus appears that during thrombingcn:ration several reactions develop that counteract 
-tirombin 
generition.
a) Thrombin inactivates V eventuallv.
b) Thrombin converts factor II into intermediate I, which is less reacrive.
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c)At leastoneofthe.. f ragments' 'has.acoagulat ioninhibi t ingacdon.
d\ An excess 
"r 
v"iir'ilir3;ilitt"d;;;?;in'i"g a phospholipid-Xo-Vu-Vo
-complex.
$7e are trying ro calculate the kinetics of this plocess. This is not at all finished'
b;';;;hiieft .f*t' rhi-tin.iiC* bear a stroigly. non-linear character'
Now non-linear kinetics recently hrve 
-b-ein" 
iho*n to account for several
interesting phenom.nf-t""rt *t 
"ttiilations' 
d;[tpi: t"t-:*-stltes and threshold
phenomena (20). Th;;"F;ffi;i; 
"pqfi 
to coicentration changes in time in
fifJUJi';;ilG'i;';;;;d;;nid,'idiffusionhastt.rbetakenintoaccount
*X:}h. 
Tunr*c has shown already h 1952(21) that non-linear kinetics together
with diffusion can account for contentr"tioo"-(u"ges along the,space coordinate
in pr eviously rro-og""ri*:* 
^*i
*t*"r. Id c;E appt ie d" to blo od coa 
gulati on,
i;":^ih;;iirpl.r, fii"JJi*;1J G of the threshold rype. A. local source 
(e' s'
a wound) could tiren";;;;;; disturbance that onlf 
^within 
a n"itt ttj^tl'::
;;fi'il; uig eno"gtrt? t.-uuou.thethresholdnecessary ro generate a
transltron
* 
{{:r"ffif;f:'"*;l:hr the limired explosion so characreristic of blood coagula-
tion in aiao.
SummanY
A review is given of the reaction scheme of blood coagulation' crucial are 
the
"""""pir "f 
ul ?tt" 
""t.J**it" 
ini.t""ti* of coagulation enzymes that accounts
for the 
"nt 
un""m"# 
"i;t;i;;;;ti*'v 
;nd fire ulgsel gg- effects observed'
and b) the occurrence of para--enzymes, i. 
".'tft. 
iuAors V"aid VIII' These moieties
are shown ,o u. ,"*ioiiri6iJ f*-ift" i6""incitv in blood coagulation bv 
providing
additional binding ;i]"|-ittt. in"yitt.-t,.tUJn"t. compleies' It is argued that
recognition of the ,to,'-ti"t"' charatter oipiott'tomUil conversion is 
essential
il;iliilH ii; ;if_ldirils characrer of 6lood coagulation.
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